@xconomy.com 11 days ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com 3 months ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com 6 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 1 year ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango